Tech Company Financing Transactions

Healx Funding Round

Healx secured a $56 million Series B funding round on 10/17/2019. Investors included Atomico Ventures, Amadeus Capital and Balderton Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

66-68 Hills Rd. Charter House
Cambridge, CB2 1LA
UK

Phone

Undisclosed

Website

www.healx.io

Email Address

[email protected]

Overview

Healx is a biotechnology company that develops and offers new therapeutic solutions for patients with rare diseases. The company offers Rareomics, a tool that helps researchers, charities, and individuals keep up with the latest scientific literature on many rare diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Timothy Guilliams

        

Chief Operating Officer

Kate Hilyard

        

Chief Scientific Officer

Neil Thompson

        

Chief Technical Officer

Ian Roberts

        

Co-Founder

David Brown

        

VP - Bus. Development

Michale Bouskila-Chubb

        

VP - Finance

David Campbell

        

Browse more venture capital transactions:

Prev: 10/17/2019: Lively venture capital transaction
Next: 10/17/2019: Science Exchange venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary